Psilocybin Delays Cellular Aging and Extends Lifespan in Preclinical Study
By
joak
Pure flour-power. Hearty enough to carry you through lunch.
Summary
Psilocybin, the active compound in psychedelic mushrooms, significantly delayed cellular aging and extended lifespan in a preclinical study from Emory University. Researchers observed a 50% increase in lifespan of human skin and lung cells and a 30% increase in survival in aged mice treated with psilocybin. The compound appeared to reduce oxidative stress, preserve telomeres, and improve DNA repair—key mechanisms in slowing the aging process. These findings suggest potential future applications for enhancing both lifespan and quality of life in aging populations.
Key quotes
· 4 pulledPsilocybin, the active compound derived from psychedelic mushrooms, significantly delayed cellular aging and extended lifespan in a preclinical study.
Researchers observed a 50% increase in the lifespan of human skin and lung cells and a 30% increase in survival in aged mice treated with psilocybin.
The compound appeared to reduce oxidative stress, preserve telomeres, and improve DNA repair, all key to slowing aging.
These findings suggest psilocybin may one day enhance not just lifespan but also quality of life in aging populations.
You might also wanna read
Google's Debug program seeks EPA approval to release 64 million modified mosquitoes in California and Florida
Google's Debug program plans to release up to 64 million genetically modified "good" mosquitoes in California and Florida over two years to
bit.ly·1h ago
Researchers develop phage-based preventive treatment for newborn meningitis caused by E. coli K1
Researchers from the Biozentrum, University of Basel, and ETH Zurich have developed a novel preventive treatment for newborn meningitis caus
biozentrum.unibas.ch·2h ago
Daily pill daraxonrasib doubles survival for metastatic pancreatic cancer patients with KRAS mutation
A new daily pill called daraxonrasib has been shown to double survival time for metastatic pancreatic cancer patients with a KRAS mutation.
bbc.co.uk·5h ago
Exploring the science behind quantum effects in healthcare: separating research from pseudoscience
The article explores the intersection of quantum physics and healthcare, distinguishing between pseudoscientific "quantum therapies" and leg
newscientist.com·6h ago
Experimental pill daraxonrasib nearly doubles survival time in advanced pancreatic cancer trial
A novel experimental pill called daraxonrasib has shown promise in extending survival for patients with advanced pancreatic cancer. The drug
chicagotribune.com·6h agoExperimental pill daraxonrasib nearly doubles survival time in advanced pancreatic cancer trial
A novel experimental pill called daraxonrasib has shown promise in extending survival for patients with advanced pancreatic cancer. The drug
chicagotribune.com·6h ago